Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
| Short Descr | ONC URTHL CA RNA FGFR3 GENE | Medium Descr | ONC UROTHELIAL CANCER RNA RT-PCR FGFR3 GENE ALYS | Long Descr | Oncology (urothelial cancer), RNA, analysis by real-time RT-PCR of the FGFR3 (fibroblast growth factor receptor 3) gene analysis (ie, p.R248C [c.742C>T], p.S249C [c.746C>G], p.G370C [c.1108G>T], p.Y373C [c.1118A>G], FGFR3-TACC3v1, and FGFR3-TACC3v3), utilizing formalin-fixed paraffin-embedded urothelial cancer tumor tissue, reported as FGFR gene alteration status | CLIA Waived (QW) | No | APC Status Indicator | Service Paid under Fee Schedule or Payment System other than OPPS | Berenson-Eggers TOS (BETOS) | none | MUE | 1 |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2022-01-01 | Note | Grammar correction |
| 2021-01-01 | Added | First appearance in code book. |
| 2021-01-01 | Changed | First appearance of change in code book. |
| 2020-04-01 | Changed | Medium and long descriptions changed. |
| 2020-01-01 | Added | Code added. |
Get instant expert-level medical coding assistance.